Oct 14 (Reuters) - Par Pharmaceutical Cos Inc said it was cutting 190 jobs in its generic unit and would reduce research and development expenses by focusing on completing products currently in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results